- Home
- SNTG vs GCTK Comparison
SNTG vs GCTK Comparison
Compare SNTG & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTG
- GCTK
- Stock Information
- Founded
- SNTG 2009
- GCTK 2001
- Country
- SNTG China
- GCTK United States
- Employees
- SNTG N/A
- GCTK N/A
- Industry
- SNTG Finance: Consumer Services
- GCTK Medical/Dental Instruments
- Sector
- SNTG Finance
- GCTK Health Care
- Exchange
- SNTG Nasdaq
- GCTK Nasdaq
- Market Cap
- SNTG 4.8M
- GCTK 4.1M
- IPO Year
- SNTG 2021
- GCTK N/A
- Fundamental
- Price
- SNTG $1.81
- GCTK $6.31
- Analyst Decision
- SNTG
- GCTK
- Analyst Count
- SNTG 0
- GCTK 0
- Target Price
- SNTG N/A
- GCTK N/A
- AVG Volume (30 Days)
- SNTG 6.5K
- GCTK 1.6M
- Earning Date
- SNTG 07-07-2025
- GCTK 08-12-2025
- Dividend Yield
- SNTG N/A
- GCTK N/A
- EPS Growth
- SNTG N/A
- GCTK N/A
- EPS
- SNTG N/A
- GCTK N/A
- Revenue
- SNTG $107,507.00
- GCTK N/A
- Revenue This Year
- SNTG N/A
- GCTK N/A
- Revenue Next Year
- SNTG N/A
- GCTK N/A
- P/E Ratio
- SNTG N/A
- GCTK N/A
- Revenue Growth
- SNTG N/A
- GCTK N/A
- 52 Week Low
- SNTG $1.43
- GCTK $5.16
- 52 Week High
- SNTG $3.97
- GCTK $3,756.00
- Technical
- Relative Strength Index (RSI)
- SNTG 51.43
- GCTK 43.52
- Support Level
- SNTG $1.67
- GCTK $5.71
- Resistance Level
- SNTG $1.86
- GCTK $7.25
- Average True Range (ATR)
- SNTG 0.09
- GCTK 1.53
- MACD
- SNTG 0.00
- GCTK 0.05
- Stochastic Oscillator
- SNTG 51.85
- GCTK 10.71
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.